In addition, we analyzed FGFR3 mRNA expression in NSCLC patients using the MethHC database (http://methhc.mbc.nctu.edu.tw/php/index.php) [28], and the results indicated that mRNA expression of FGFR3 in tumor (T) was escalated, compared with that in normal (N) samples (Figure 1(e)). The gene discussed is FGFR3; the disease is neoplasm.